Jan. 5, 2007 — A report in the January issue of the Journal of the American College of Cardiology finds that as many as ...
Jan. 5, 2007 — MedicalCV, Inc., a cardiovascular surgery company, says it will amend its 510(k) submission for clearance ...
Jan. 5, 2007 — A French court has ruled that Abbott Laboratories’ Xience V drug-eluting coronary stents infringe patents ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
AP reports that a Dec. 27 Medicare proposal may could double the number of hospitals authorized to implant the HeartMate ...
HMS Technologies, Inc. (HMS), the exclusive federal distributor for the commercial versions of the EZ-IO Emergency ...
Non-white, low-income patients without commercial insurance are more likely to delay diagnosis of peripheral vascular ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Dual-chamber pacing coupled with Boston Scientific's AV Search Hysteresis (AVSH) programming has the potential to reduce ...
A review by physicians at Tulane University School of Public Health and Tropical Medicine shows that Vitamin B12 ...
Heartwire cites results of a new study finding that current heart-failure performance measures, with the exception of ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Implant Sciences Corp. a wholly-owned German subsidiary of CorNova, Inc., has received CE Mark marketing approval for ...
Swiss researchers may have discovered the reason drug-eluting stents cause thrombosis, and their study results are ...
Reuters reports that a study of military veterans suffering from post-traumatic stress disorder showed that more severe their anxiety, the greater their risk of heart disease. Adding to the long-recognized connection between stress and heart disease, researchers at the Harvard School of Public Health in Boston said that relationship existed among nearly 2,000 Boston-area veterans.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
A new intravascular MRI catheter developed by Topspin Medical has received CE Mark approval, and the Israeli company ...
The latest in thrombus removal devices from Possis has received FDA clearance — the new AngioJet Ultra Thrombectomy System is the next-generation, re-engineered version of the company’s AngioJet Rheolytic Thrombectomy System.
The first patients to receive a new, implanted heart-monitoring device underwent procedures recently at the Clinica ...
January 04, 2007
